All News #Library
Rare Diseases
ImmuneSensor Doses First Patient in Phase 1b IMSB-301 AGS Trial
12 Feb 2026 //
GLOBENEWSWIRE
ImmuneSensor Receives Orphan Drug & Rare Disease Designations
20 Nov 2024 //
GLOBENEWSWIRE

Market Place
Sourcing Support